- Lobbying
- texas AND pharmacy
Lobbying Arrangements Results for 'Texas Pharmacy'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Medicare Prescription Drug Improvement and Modernization Act of 2003 Medicaid reform |
Texas Pharmacy Association
support of the Texas pharmacy industry |
IMPACT TEXAS COMMUNICATIONS, LLP | |||
Details Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. |
Texas Academy of Compounding Pharmacists
|
HANCE SCARBOROUGH | |||
Details Federal legislation affecting the practice of pharmacy, and FDA and DEA regulations of compounded drugs. Federal legislation affecing the practice of pharmacy, and FDA and DEA regulations of compou... |
Alliance of Independent Pharmacists - Texas
|
HANCE SCARBOROUGH | |||
Details Congressional oversight of drug safety |
Actavis Inc
Devlopment, Manufacture, and Sale of First-Class Generic Pharmaceuticals |
Ryan, Phillips, Utrecht & MacKinnon | |||
Details Issues related to the disease of diabetes, diabetes therapies and management of the disease of diabetes. Issues related to medical devices and medical device technology. Issues related to medical ... |
Insulet Corporation
|
in-house lobbying | |||
Details Advocated for the continued funding of the Children's Hospitals Graduate Medical Education (CHGME) program which funds pediatric residency training at children's hospitals. Advocated for continued... |
TEXAS CHILDREN'S HOSPITAL
|
in-house lobbying | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. Issues pertaining to Prescription Drug Monitoring. Public Health. Monitor legislation and oversight o... |
American Society of Interventional Pain Physicians
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Issues related to Medicare reimbursements for cancer services. Any legislation having to do with Medicare payments for dedicated cancer centers and hospitals; Medicare Advantage and preauthorizatio... |
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
|
in-house lobbying | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. |
AmerisourceBergen Corporation
Health care interests |
Farragut Partners LLP | |||
Details Public health, medication adherence |
PrescribeWellness
|
Ryan MacKinnon Vasapoli and Berzok LLP | |||
Details Legislation affecting market exclusivity for antibiotics |
Medicis Pharmaceutical Corporation
|
Ryan, MacKinnon, Vasapoli and Berzok, LLP FKA Ryan,Phillips, Utrecht & MacKinnon | |||
Details FY10 LHHSED Appropriations (CDC); FY10 Transportation HUD Appropriations (EDI) |
Hance Scarborough, LLP
|
RH Strategies, LLC | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; H.R. 1934 Canc... |
Community Oncology Alliance
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details 10/11/23 - Kathleen O'Neill talked to Alaura Ervin in Sen. John Cornyns office and Franci Rooney on Senate Judiciary Committee staff about Name Image Likeness and other issues pertaining to a heari... |
The University of Texas at Austin
|
in-house lobbying | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare part B and sequestration. Issues pertaining to Federal Drug Pedigree and Drug Shortages. |
AmerisourceBergen Corporation
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Congressional oversight relating to drug safety and healthcare. |
MERCK & CO.
|
Ryan MacKinnon Vasapoli and Berzok LLP FKA Ryan Phillips Utrecht and MacKinnon | |||
Details Concerns regarding Meicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Issues related to the implementation of the follow-on biologics provisions in P.L. 11... |
GENENTECH
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Implementation of Family Smoking Protection and Tobacco Control Act of 2009 and FDA Tobacco Product Deeming proposed Rule CDC's implementation of health care funding provisions of P.L. 111-148, the... |
ALTRIA CLIENT SERVICES INC
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Congressional oversight of drug safety/ |
Actavis Inc
|
Ryan MacKinnon Vasapoli and Berzok LLP FKA Ryan Phillips Utrecht and MacKinnon | |||
Details Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legi... |
Community Oncology Alliance
|
Farragut Partners LLP | |||
Details Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation. Issues related to insurance market stabili... |
Blue Cross Blue Shield Association
|
Farragut Partners LLP | |||
Details Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B r... |
Genentech
|
Farragut Partners LLP | |||
Details Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation |
Heron Therapeutics, Inc.
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. Issues related to ambulatory surgery centers. Opioid and prescription drug monitoring programs. U.S. S... |
American Society of Interventional Pain Physicians
|
Farragut Partners LLP | |||
Details * Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act * No Specific Bill Number. Funding for medical countermeasure enterprise including, Strategic National Stock... |
Emergent Biosolutions Inc.
|
THE OB-C GROUP, LLC | |||
Details General budget, appropriations and education matters. |
Becker College
Budget, appropriations and education. |
The Normandy Group, LLC | |||
Details P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B; H.R.6 21st Century Cures Act; FDA in HR 3049 FY16 Agricultu... |
Novo Nordisk
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Affordable Care Act Issues: Small group expansion; Risk Corridors; Delivery system reform; Consumer experience; Back end issues; Implementation issues; Regulations; Premiums; Exchanges; Supreme Cou... |
BLUE CROSS BLUE SHIELD ASSOCIATION
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Animal research The un- and underinsured, animal research, clinical trials, scientific misconduct,conflict of interest. S. 717 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Rese... |
The University of Texas M.D. Anderson Cancer Center
|
PODESTA GROUP, INC. | |||
Details HR 6683 Preserving Seniors Access to Physicians Act (Murphy, Davis, Wenstrup, Panetta): Stops the Medicare 3.4% Payment Cut HR 6545 The Physician Fee Schedule Updates and Improvement Act (E&C Comm... |
California Medical Association Inc.
|
in-house lobbying | |||
Details -H.R. 5378 - Lower Costs More Transparency Act, Provisions related to pharmacy benefit manager price transparency, authorization of funding for community health centers, delay of disproportionate s... |
AFL-CIO
|
in-house lobbying | |||
Details H.R.4917 - Expanding Seniors Access to PFAS Testing Act Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers ... |
American Association for Justice
|
in-house lobbying | |||
Details Expand Patient Access and Telehealth: Urged Congress to support several bills to expand patient access to medical coverage. ACP supports H.R. 1114, the Long COVID Response is Care Optimized and Vit... |
American College of Physician Services, Inc.
|
in-house lobbying | |||
Details Expand Patient Access and Telehealth: Urged Congress to support several bills to expand patient access to medical coverage. ACP supports H.R. 1114, the Long COVID Response is Care Optimized and Vit... |
AMERICAN COLLEGE OF PHYSICIANS
|
in-house lobbying |